Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the page footer and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-06T11:36:35.000Z thumbnail image
  2. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed. This update affects only the site's release notes on the history page.
    Difference
    0.0%
    Check dated 2026-02-05T14:18:05.000Z thumbnail image
  3. Check
    12 days ago
    Change Detected
    Summary
    UI enhancements were introduced: a glossary display and color-coded change highlights (green for additions, red for deletions) with a revision note updated to v3.4.0. Additionally, capitalization of 'No FEAR Act Data' was corrected and the older 'No FEAR Act data' phrasing removed.
    Difference
    0.1%
    Check dated 2026-01-29T06:22:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added, replacing the previous Revision: v3.3.3. This appears to be an informational site revision tag rather than a change to study content or user actions.
    Difference
    0.0%
    Check dated 2026-01-15T02:54:33.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.3.3 is added to the page, and HHS Vulnerability Disclosure and Revision: v3.3.2 are removed.
    Difference
    0.0%
    Check dated 2025-12-24T14:29:06.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    New entries for Contacts/Locations and Study Status were added on 2025-11-14 and 2025-12-02, and an entry was removed on 2025-11-10.
    Difference
    0.1%
    Check dated 2025-12-02T17:44:19.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.